Bromelain inhibitor (BI) is a cysteine proteinase inhibitor isolated from pineapple stem (Reddy, M. N., Keim, P. S., Heinrikson, R. L., and Ké zdy, F. J. (1975) J. Biol. Chem. 250, 1741-1750). It consists of eight isoinhibitors, and each isoinhibitor has a two-chain structure. In this study, the genomic DNA has been cloned and found to encode a precursor protein with 246 amino acids (M r ؍ ϳ27,500) containing three isoinhibitor domains (BI-III, -VI, and -VII) that are 93% identical to one another in amino acid sequences. The gene structure indicated that these isoinhibitors are produced by removal of the N-terminal pre-peptide (19 residues), 3 interchain peptides (each 5 residues), 2 interdomain peptides (each 19 residues), and the C-terminal pro-peptide (18 residues). Moreover, all the amino acid sequences of bromelain isoinhibitors could be explained by removal of one or two amino acids from BI-III, -VI, and -VII with exopeptidases. A recombinant single-chain BI-VI with and without the interchain peptide showed the same and no bromelain inhibitory activity as compared with the native BI-VI, respectively. These results indicate that the interchain peptide plays an important role of the folding process of the mature isoinhibitors.Most cysteine proteinase inhibitors obtained from plants so far have been identified as cystatins including inhibitors from rice, corn, soybean, and tomato (1). Their properties have been extensively studied, including their nucleotide and amino acid sequences and three-dimensional structures. Reddy et al. (2) have isolated a novel and microheterogeneous inhibitor toward bromelain (BI) 1 from pineapple (Ananas comosus) stem (2). Each isoform of BI consists of a light chain (10 or 11 residues) and a heavy chain (40 or 41 residues) that are cross-linked with disulfide bonds (2-4). The three-dimensional solution structure of the sixth isoinhibitor (BI-VI N ) has two distinct domains named A and B domains, each of which is formed by a threestranded antiparallel -sheet (5, 6). The B domain consists of the light chain and part of the heavy chain (Glu 1H -Asp 9H and Leu 31H -Lys 41H ) 2 and was indicated to involve the major bromelain inhibitory site, possessing a more flexible structure that seems to allow the inhibitor to fit well into the catalytic site region of a target proteinase (4, 6). On the other hand, the structure of the A domain (Thr 10H -Ile 29H ) was well converged and, thus, thought to contribute greatly to the conformational stability of the B domain (6).BI has no similarity to the cystatin superfamily inhibitors in the primary structure (1) and has no Gln-X-Val-X-Gly sequence that is essential for activity against papain and other cysteine proteinases (7). For example, the structure of BI-VI N shows no homology with that of rice cystatin that consists of an ␣-helix and a five-stranded antiparallel -sheet (8). Interestingly, BI-VI N shared the same folding and disulfide bond connectivities with Bowman-Birk serine proteinase inhibitor (BBI) from soybean (6), a 71-residue in...